Tailored cytomegalovirus management in lung transplant recipient: A single-center experience

Transplantation Proceedings

Volumn 45, Issue 7, 2013, Pages 2736-2740

  Solidoro, P ^a   Costa, C ^b   Libertucci, D ^a   Sidoti, F ^b   Boffini, M ^b   Ricci, D ^b   Delsedime, L ^b   Cavallo, R ^b   Baldi, S ^a   Rinaldi, M ^b  

^a CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYTOMEGALOVIRUS ANTIBODY; EVEROLIMUS; GANCICLOVIR; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; VALGANCYCLOVIR;

ACUTE GRAFT REJECTION; ANTIVIRAL THERAPY; BRONCHIOLITIS; BRONCHITIS; CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSPOT ASSAY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FOLLOW UP; GRAFT RECIPIENT; HEALTH CARE COST; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MIXED INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; STEROID THERAPY; VIRUS LOAD; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; HUMANS; IMMUNOGLOBULINS; LUNG TRANSPLANTATION; POLYMERASE CHAIN REACTION;

EID: 84884408512     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.07.013     Document Type: Conference Paper

References (17)

1. D.R. Snydman, A.P. Limaye, L. Potena, and M.R. Zamora Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation Transplant Proc 43 3 Suppl 2011 S1 S17
2. M. Boffini, V.M. Ranieri, and M. Rinaldi Lung transplantation: is it still an experimental procedure? Curr Opin Crit Care 16 1 2010 53 61
3. J.D. Christie, L.B. Edwards, and P. Aurora Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report - 2008 J Heart Lung Transplant 27 2008 957
4. W.J. Waldman, D.A. Knight, P.W. Adams, C.G. Ororsz, and D.D. Sedmak In vitro induction of endothelial HLA class II antigen expression by CMV-activated CD4+ T cells Transplantation 56 1993 1504 1512
5. G. Gerna, D. Lilleri, and V. Rognoni Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients Am J Transplant 9 2009 1142 1150
6. Costa C, Curtoni A, Solidoro P, Delsedime L, Bergallo M, Cavallo R. Quantification of human cytomegalovirus in transbronchial biopsies from lung transplant recipients. Arch Virol. 2013 Jul;158(7):1461-5.
7. R.S. Rhada, D. Jordan, and S. Puliyanda Cellular immune responses to cytomegalovirus in renal transplant recipients Am J Transplant 5 2005 110 117
8. O.A. Shlobin, E.E. West, and N. Lechtzin Persistent cytomegalovirus- specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients J Immunol 176 2006 2625 2634
9. A. Chiereghin, L. Gabrielli, and C. Zanfi Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients Transplant Proc 42 2010 69 73
10. P. Solidoro, D. Libertucci, and L. Delsedime Combined cytomegalovirus prophylaxis in lung transplantation: effects on acute rejection, lymphocytic bronchitis/bronchiolitis, and herpesvirus infections Transplant Proc 40 2008 2013 2014
11. C.C. Bauer, P. Jaksch, and S.W. Aberle Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment J Clin Microbiol 45 2007 324
12. P. Solidoro, L. Delsedime, and M. Bergallo Combined prophylaxis decreases incidence of CMV-associated pneumonia after lung transplantation Transplant Proc 41 2009 1347 1348
13. C. Costa, S. Astegiano, and M.E. Terlizzi Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients Transplant Proc 43 2011 1159 1161
14. U. Sester, B.C. Gärtner, and H. Wilkens Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation Am J Transplant 5 2005 1483
15. C. Costa, A. Saldan, and F. Sinesi Does everolimus associated with a low dose of cyclosporine in long-term cardiac transplant recipients improve renal function? Initial experience Int J Immunopathol Pharmacol 25 4 2012 1003 1009
16. M. Boffini, F. Sansone, and F. Patanè Does everolimus associated with a low dose of cyclosporine in long-term cardiac transplant recipients improve renal function? Initial experience Transplant Proc 41 4 2009 1349 1352
17. M. Viganò, T. Dengler, and M.F. Mattei Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study Transpl Infect Dis 12 1 2010 23 30